+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dry Eye Disease Market, By Product, By Distribution Channel, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

  • PDF Icon

    Report

  • 163 Pages
  • December 2022
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5714431
Dry eye disease (DED) is the condition that occurs when tears are not able to provide adequate lubrication to eyes. DED is a multifactorial disease of the ocular surface with loss of homeostasis of the tear film and ocular symptoms. Over-the-counter (OTC) eye drops, such as artificial tears, and prescription eye drops, are effective treatments for dry eye.

Market Dynamics:

Rising incidence of dry eye disease worldwide, rise in demand for safe and effective treatment, rise in focus on the development of novel therapeutics, growing geriatric population, emergence of novel diagnostic tools, and technological advancements are major factors expected to propel the growth of the global dry eye disease market.

For instance, in February 2022, Viatris Inc. announced that its subsidiary, Mylan Pharmaceuticals Inc., received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclosporine Ophthalmic Emulsion 0.05%, the first generic version of Allergan's Restasis, to treat dry eye disease.

Moreover, in October 2021, Oyster Point Pharma, Inc. announced that the U.S. FDA has approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of signs and symptoms of dry eye disease. Nasal spray administration provides a new way to treat dry eye disease without administering medication onto an already irritated ocular surface.

Key Features of the Study:

  • This report provides in-depth analysis of the global dry eye disease market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global dry eye disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include VISUfarma, Johnson & Johnson, Otsuka Holdings Co. Ltd., OASIS Medical, Novartis AG, Sentiss Pharma Pvt. Ltd., AbbVie Inc. (Allergan PLC), Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global dry eye disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dry eye disease market.

Detailed Segmentation:

Global Dry Eye Disease Market, By Product:

  • Artificial Tears
  • Anti-Inflammatory Drugs
  • Punctal Plugs
  • Secretagogues
  • Other Products

Global Dry Eye Disease Market, By Distribution Channel:

  • Hospital Pharmacies
  • Independent Pharmacies and Drug Stores
  • Online Pharmacies

Global Dry Eye Disease Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America

Company Profiles:

  • VISUfarma
  • Johnson & Johnson
  • Otsuka Holdings Co. Ltd.
  • OASIS Medical
  • Novartis AG
  • Sentiss Pharma Pvt. Ltd.
  • AbbVie Inc. (Allergan PLC)
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Geography
  • Publisher Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Rising incidence/prevalence of dry eye disease across the globe
  • Availability of alternative therapies and high cost of dry eye products
  • Increase in focus on the development of dry eye disease treatment
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Merger and Acquisition Scenario
4. Global Dry Eye Disease Market - Impact of Coronavirus (COVID-19) Pandemic
  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact
5. Global Dry Eye Disease Market, By Product, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Artificial Tears
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Anti-Inflammatory Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Punctal Plugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Secretagogues
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Dry Eye Disease Market, By Distribution Channel, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Independent Pharmacies and Drug Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Dry Eye Disease Market, By Geography, 2017-2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
8. Competitive Landscape
  • VISUfarma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Otsuka Holdings Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • OASIS Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Sentiss Pharma Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • AbbVie Inc. (Allergan PLC)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Santen Pharmaceutical Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Analyst Views
9. Section
  • Research Methodology
  • About the Author

Companies Mentioned

A selection of companies mentioned in this report includes:

  • VISUfarma
  • Johnson & Johnson
  • Otsuka Holdings Co. Ltd.
  • OASIS Medical
  • Novartis AG
  • Sentiss Pharma Pvt. Ltd.
  • AbbVie Inc. (Allergan PLC)
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.